Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer (Division of Gene Therapy Science, Dr. Nimura Laboratory) へのコメント

Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer (Division of Gene Therapy Science, Dr. Nimura Laboratory) へのコメント https://www.giar.gunma-u.ac.jp/eng/development-of-a-synthetic-lethality-based-combination-therapy-using-lig1-and-parp-inhibitors-for-prostate-cancer/ Just another WordPress site Fri, 12 Dec 2025 08:46:34 +0000 hourly 1 https://wordpress.org/?v=6.9.4